GFPC
NVAX icon

Global Financial Private Client’s Novavax NVAX Stock Holding History

Global Financial Private Client’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$6 – 1142
2025
Q1 		$6 Hold
1
– – ﹤0.01% 1670
2024
Q4 		$8 Hold
1
– – ﹤0.01% 1659
2024
Q3 		$13 Hold
1
– – ﹤0.01% 807
2024
Q2 		$13 Hold
1
– – ﹤0.01% 683
2024
Q1 		$5 Hold
1
– – ﹤0.01% 702
2023
Q4 		$5 Hold
1
– – ﹤0.01% 687
2023
Q3 		$7 Hold
1
– – ﹤0.01% 682
2023
Q2 		$7 Hold
1
– – ﹤0.01% 672
2023
Q1 		$7 Hold
1
– – ﹤0.01% 686
2022
Q4 		$10 Buy
+1
New +$18 ﹤0.01% 680

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Global Financial Private Client's NVAX Position: Q2 2025 in Review

Global Financial Private Client sold out of Novavax (NVAX) in Q2 2025, closing a stake of 1 share — an estimated $6 sold.

Global Financial Private Client first reported a position in NVAX in Q4 2022 and held it in 10 quarters. The position peaked at $13 in Q3 2024. 250 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.

  • Global Financial Private Client reported no remaining Novavax position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 1 Novavax share in Q2 2025, an estimated $6.
  • Global Financial Private Client first reported a position in Novavax in Q4 2022 and held it in 10 quarters.
  • Global Financial Private Client's Novavax position peaked at $13 in Q3 2024.
  • 250 funds tracked by Wall St. Rank held Novavax as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.